Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 15, 2022
Patent Application Number
15739200
Date Filed
June 24, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed are a means to convert compounds having physiological or pharmacological activity and unable to pass through the blood-brain barrier into a form that allows them to pass through the blood-brain barrier, and compounds converted thereby. The means is an anti-human transferrin receptor antibody and the converted compounds are molecular conjugates between physiologically active protein or pharmacologically active low-molecular-weight compounds and an anti-human transferrin receptor antibody.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
